Pollock TM, Morris J. A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet 1983;1:753-757.

Prince GA, Jenson AB, Billups LC, Notkins AL. Infection of human pancreatic beta cell cultures with mumps virus. Nature 1978;271:158-161.

Puvvada L, Silverman B, Bassett C, Chiaramonte LT. Systemic reactions to measles-mumps-rubella vaccine skin testing. Pediatrics 1993;91:835-836.

Quast U, Hennessen W, Widmark RM. Vaccine induced mumps-like diseases. Developments in Biological Standardization 1979;43:269-272.

Rayfield EJ, Kelly K J, Yoon JW. Rubella virus-induced diabetes in the hamster. Diabetes 1986;35:1278-1281.

Reed D, Brown G, Merrick R, et al. A mumps epidemic on St. George Island, Alaska. Journal of the American Medical Association 1967;199:113-117.

Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta Neurologica Scandinavica 1989;80:425-431.

Robbins FC. Measles: clinical features, pathogenesis, pathology, and complications. American Journal of Diseases of Children 1962;103:266-273.

Rubinstein P, Walker ME, Fedun B, Witt ME, Cooper LZ, Ginsberg-Fellner F. The HLA system in congenital rubella patients with and without diabetes. Diabetes 1982;31:1088-1091.

Sandler B. Recovery from sterility after mumps orchitis. British Medical Journal 1954;11:795.

Saxton NL. Thrombocytopenic purpura following the administration of attenuated live measles vaccine. Journal of the Iowa Medical Society 1967;57:1017-1018.

Schacher SA. An epidemiological approach to subacute sclerosing panencephalitis. Neurology 1968;18(1 Pt 2):76-77.

Schneck SA. Vaccination with measles and central nervous system disease. Neurology 1968;18(Pt 2):79-82.

Schwarz AJ. Immunization against measles: development and evaluation of a highly attenuated live measles vaccine. Annales de Paediatrie 1964;202:241-252.

Schwarz AJ, Anderson JT. Immunization with a further attenuated live measles virus vaccine. Archiv fur Gesamte Virusforschung 1965;16:273-278.

Schwarz A J, Jackson JE, Ehrenkranz NJ, Ventura A, Schiff GM, Walters VW. Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. American Journal of Diseases of Children 1975;129:1408-1412.

Sinaniotis CA, Daskalopoulou E, Lapatsanis P, Doxiadis S. Diabetes mellitus after mumps vaccination (letter). Archives of Disease in Childhood 1975;50:749-750.

Sokhey J. Adverse events following immunization: 1990. Indian Pediatrics 1991;28:593-607.

Srivastava RN, Bagga A. Hemolytic uremic syndrome: recent developments. Indian Pediatrics 1992;29:11-24.

Starke G, Hlinak P, Nobel B, Winkler C, Kaesler G. Maserneradikation—eine Moglichkeit? Ergebnisse und Erfahrungen mit der Masernschutzimpfung 1967 bis 1969 in der DDR [Measles control—a possibility? Results and experiences with measles vaccination from 1967 to 1969 in the German Democratic Republic.] Deutsche Gesundheit-Wesen 1970;25:2384-2390.

Stokes JJ, Maris EP, Gelles SS. Chemical, clinical, and immunologic studies on the products of human plasma fractionation. XI. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. Journal of Clinical Investigations 1944;23:531-540.

Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatric Infectious Disease Journal 1991;10:209-213.

Sultz HA, Hart BA, Zielezny M, Schlesinger ER. Is mumps virus an etiologic factor in juvenile diabetes mellitus? Journal of Pediatrics 1975;86:654-656.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement